Purchases and Sales Made in Q1 2023 in Kinnate Biopharma Inc. (KNTE)
This table provides information about the institutional ownership of Kinnate Biopharma Inc. (KNTE) during Q1 2023. The information is specifically focused on institutions that hold shares of Kinnate Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-16.4K- 91.66% |
$56.8K - $131K
|
1.5K
$0
|
|
|
May 15, 2023
Q1 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-16.7K- 16.96% |
$57.9K - $134K
|
82K
$0
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-29.8K- 2.7% |
$103K - $238K
|
1.07M
$0
|
|
|
May 12, 2023
Q1 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-33.1K- 47.1% |
$114K - $264K
|
37.1K
$0
|
|
|
May 15, 2023
Q1 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-52.7K- 4.35% |
$182K - $421K
|
1.16M
$0
|
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-58.7K- 2.51% |
$203K - $468K
|
2.28M
$0
|